The latest report by IMARC Group, titled “Immunohematology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“. The global immunohematology market size reached US$ 1.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2028, exhibiting a growth rate (CAGR) of 4.7% during 2023-2028.
Immunohematology is a medical field that investigates the relationship between the immune system and blood or blood-forming tissues. It is employed to study the presence of antigens, Rhesus (Rh) factor, plasma, and white blood cell (WBC) components in the blood and their interactions with antibodies that may lead to hemolysis or red blood cell (RBC) agglutination. A range of immunohematology tests is performed to secure safe blood transfusions, prevent undesired immune reactions related to transplants and pregnancies, and diagnose blood-related diseases and disorders such as human immunodeficiency virus (HIV) and Hepatitis. They deploy several chemicals and devices, including reagents, automated and semi-automated analyzers based on the technology of gel cards, microplates, biochips, polymerase chain reaction (PCR), and erythrocyte-magnetized technology (EMT). As a result, immunohematology is widely adopted in blood banks, diagnostic laboratories, and hospitals across the globe.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/immunohematology-market/requestsample
Immunohematology Market Trends and Drivers:
The market is primarily driven by the growing occurrences of blood-related diseases such as leukemia and other hematological disorders. In addition, the development of healthcare infrastructure, blood banks, and trauma centers, particularly in developing nations, is contributing to market growth. Moreover, several technological advancements, including the development of innovative transfusion systems and fully automated devices, represent another major growth-inducing factor. Additionally, the next generation of immunohematology devices helps minimize analysis time and human error, improve diagnosis accuracy, and provide emergency care to patients, thus influencing market growth. In line with this, the rising investment by public and private organizations in constructing blood banks and the growing awareness among individuals regarding the process involved in blood collection, processing, testing, and storage are accelerating the product adoption rate. Besides this, numerous governments are taking the initiative to create awareness programs to educate individuals regarding the importance of blood donation and safe blood and blood products, thus increasing the number of blood donation camps and driving the market growth. Apart from this, the immunohematology market is growing at different rates in numerous regions, with the North American region being one of the largest immunohematology markets due to the rising number of trauma centers and blood bank facilities. Moreover, the industry is expected to face competition in the forthcoming years as various key players are implementing competitive strategies to sustain their presence in the market. For instance, in 2019, Alcor Scientific introduced miniiSED, an automated sedimentation rate analyzer that reports the sedimentation rate in mm/hr. Additionally, in the same year, Sight Diagnostics launched Olo, an automated hematology analyzer that can provide quantitative and multiparameter results designed for use in clinical laboratories. Furthermore, new product launches, extensive investment in research and development (R&D) activities, and mergers and acquisitions (M&A) among key market players are creating a positive market outlook.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product:
- Analyzing Systems
- Reagents and Consumables
Breakup by Technology:
- Biochips
- Gel Cards
- Microplates
- Polymerase Chain Reaction
- Erythrocyte-Magnetized Technology (EMT)
- Others
Breakup by Application:
- Blood-Related Diseases
- HIV
- Hepatitis
- Blood Transfusion
- Others
Breakup by End-User:
- Hospitals
- Blood Banks
- Diagnostic Laboratories
- Others
Breakup by Region:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East & Africa
Competitors Landscape with Key Players:
- Abbott, Antisel
- BD
- Beckman Coulter Inc. (Danaher Corporation)
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Grifols S.A.
- Merck KGaA
- MTC Invitro Diagnostics AG
- Ortho-Clinical Diagnostics Inc (The Carlyle Group)
- Siemens Healthcare GmbH
- Thermo Fisher Scientific Inc.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
